Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

New methodology reduces the data requirements for protein engineering by 99% so organizations can unlock innovation even in ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

Budget amendments from the governor and the House of Delegates both include $5 million in funding for the Roanoke project.